The scaffolding protein and associated protease of the human herpesvirus varicella-zoster virus (VZV), encoded by genes 33n5 and 33 respectively, were synthesized in insect cells using a baculovirus expression system. The expressed 33n5 product formed numerous long, flexible, hollow rods, and in this respect differed from the herpes simplex virus type 1 (HSV-1) homologue which forms large aggregates consisting mainly of fibrous material interspersed with scaffold-like particles. Removal of 27 amino acids from the carboxy terminus of the VZV scaffolding protein by the gene 33 protease or expression of the cleaved product did not result in any discernible change in the morphology of the scaffolding protein. Again, this was in marked contrast to the situation in HSV-1 where removal of the 25 carboxy-terminal amino acids from the
Introduction
The herpesvirus capsid assembles around an internal scaffold which is subsequently lost during packaging of the viral genome. The scaffolding proteins are specified by two overlapping, in frame, 3h-coterminal genes in herpes simplex virus type 1 (HSV-1) and this organization is conserved in all herpesviruses that have been examined so far (Baer et al., 1984 ; Davison & Scott, 1986 ; Chee et al., 1990 ; Griffin, 1990 ; Liu & Roizman, 1991 a ; Welch et al., 1991 ; Albrecht et al., 1992 ; Telford et al., 1992 Telford et al., , 1995 Gompels et al., 1995 ; Haanes et al., 1995 ; Steffy et al., 1995 ; Camacho & Tabares, 1996 ; Nicholas, 1996) (refer to Fig. 1 a) . The larger gene encodes a serine protease which cleaves itself at two positions, generating a small capsid protein containing the catalytic domain of the Author for correspondence : Valerie Preston.
Fax j44 141 337 2236. e-mail V.PRESTON!VIR.GLA.AC.UK scaffolding protein by the associated protease or expression of VP22a results in the formation of large numbers of scaffold-like particles. Despite these differences, when cells were multiply infected with baculoviruses expressing the HSV-1 capsid shell proteins and the VZV scaffolding protein complete capsids were observed, suggesting that the VZV protein could act as a scaffold for the assembly of the HSV-1 capsid shell. The efficiency of capsid assembly was increased substantially by exchanging the 23 carboxy-terminal amino acids of the VZV scaffolding protein for the corresponding 22 carboxy-terminal amino acids of the HSV-1 homologue, supporting previous work which showed that this region was critical for the formation of intact capsids.
protease and a minor scaffolding protein (Davison et al., 1992 ; DiIanni et al., 1993 DiIanni et al., a, 1994 Liu & Roizman, 1993) . The product of the smaller gene, the major component of the scaffold, is also processed by the protease (Liu & Roizman, 1991 b ; Preston et al., 1992) . The carboxy-terminal amino acids of the uncleaved scaffolding proteins bind to the major capsid protein VP5 and this interaction is essential for formation of the capsid (Kennard et al., 1995 ; Thomsen et al., 1995 ; Hong et al., 1996 ; Desai & Person, 1996) . Cleavage of the scaffold by the protease leads to the removal of the carboxy-terminal amino acids from the scaffolding proteins. This process, which weakens the association between the scaffold and the major capsid protein, is essential for the exit of the scaffold from the capsid and subsequent packaging of the virus genome (Preston et al., 1983 ; Gao et al., 1994) .
Recently, HSV-1 immature capsids have been assembled in insect cells multiply infected with recombinant baculoviruses expressing HSV-1 capsid proteins. Of the four outer shell proteins, VP5, which forms the hexameric and pentameric capsomers of the icosahedral capsid, and the two proteins, VP19C and VP23, which form intercapsomeric connections (Schrag et al., 1989 ; Booy et al., 1991 ; Newcomb et al., 1993) , are essential for capsid formation using the baculovirus system (Tatman et al., 1994 ; Thomsen et al., 1994) . The remaining capsid shell protein, VP26, which is found on top of each hexon, is dispensable (Booy et al., 1994 ; Tatman et al., 1994 ; Thomsen et al., 1994 ; Zhou et al., 1994) . The major scaffolding protein (the UL26n5 product), in the absence of the protease, can act as a scaffold and, similarly, the protease (the UL26 product) can substitute for the major scaffolding protein although capsid assembly was much less efficient due to the rapid cleavage of the carboxy terminus of the minor scaffolding protein (Tatman et al., 1994 ; Thomsen et al., 1994) . These findings have been confirmed and extended using HSV-1 mutants (Gao et al., 1994 ; Matusick-Kumar et al., 1994) .
Varicella-zoster virus (VZV), like HSV-1, is a human herpesvirus belonging to the subfamily Alphaherpesvirinae. Its morphology is very similar to that of other herpesviruses and a major component of the nucleocapsid, thought to be analogous to the HSV-1 UL26n5 product, has been described (Friedrichs & Grose, 1986) . In this paper, we have extended the early observations on the scaffolding proteins by Friedrichs & Grose (1986) and compared the proteins with those of HSV-1. The aim of the work is to provide information on the requirements for, and constraints on, capsid assembly and to help identify key regions in the scaffolding protein.
Methods
Cells and viruses. SF21-AE cells and BHK-21 clone 13 cells were cultured as described previously (Kennard et al., 1995) . The parental virus used to construct the recombinant baculoviruses was AcPAK6. Baculoviruses containing the HSV-1 genes UL26, UL26n5, UL18, UL19, UL38 and a mutant form of UL26n5, expressing VP22a, have been described previously (Preston et al., 1994 ; Tatman et al., 1994 ; Kennard et al., 1995 (Nicholson et al., 1994) .
Baculovirus expression vector containing HSV-1 genes UL18, UL19 and UL38. The baculovirus expression vector pAcAB3 (Belyaev & Roy, 1993) was cleaved with XbaI and StuI and the larger fragment ligated to an XbaI-HincII fragment, containing the UL38 gene derived from pBJ382 (Tatman et al., 1994) . The resulting plasmid was referred to as pAcAB3.1. The Sal I site in pT318, containing the UL18 gene (Tatman et al., 1994) , was converted to a BamHI site to enable the UL18 gene to be cloned as a BamHI fragment into the Bgl II site of pAcAB3.1. The UL19 gene from pJN6 (Nicholson et al., 1994) was cloned as a Bgl II fragment into the unique BamHI site of the baculovirus expression vector pAcAB3.11, containing both UL18 and UL38 genes, to form pAcAB3.7. Antibodies. Mouse monoclonal antibodies used were 406 (Serotec) and 5010 (Rixon et al., 1988) , specific for sequences within HSV-1 VP22a, LP12, which recognizes HSV-1 major capsid protein VP5, and 9220 (DuPont), which recognizes a 10 amino acid sequence (pp65 epitope) from the HCMV UL83 product (McLauchlan et al., 1994) . Rabbit antiserum 64 was raised against the peptide GEPTYITHRRRRVSPS (amino acid residues 471-486 of the VZV 33 ORF) coupled to the carrier protein keyhole limpet haemocyanin via the serine residue. Rabbit VZV scaffolding protein and protease VZV scaffolding protein and protease antiserum 108, raised against the peptide ADDADMFANQMMVGRC (amino acid residues 590-605 of the VZV 33 ORF), was also coupled to keyhole limpet haemocyanin but via the cysteine residue. Rabbit antibody 20999, specific for the 14 amino acids adjacent to the carboxy-terminal residue of the HSV-1 UL26 and UL26n5 product, has been described elsewhere (Preston et al., 1992) . In indirect immunofluorescence experiments primary mouse and rabbit antibodies bound to antigen were detected using fluorescein isothiocyanate-conjugated goat anti-mouse IgG (FITC-GAM) and tetramethylrhodamine isothiocyanate-conjugated goat anti-rabbit IgG (TRITC-GAR) (Sigma) respectively. In immunoelectron microscopy, goat anti-rabbit IgG coupled to 10 nm colloidal gold particles (British Biocell International) was used as a secondary antibody.
Immunofluorescence and immunoblotting. Immunofluorescence studies were carried out as described by Nicholson et al. (1994) and the procedure for immunoblotting was performed as outlined by Preston et al. (1994) , using colloidal gold particles bound to protein A followed by silver enhancement to detect VZV and HSV-1 proteins.
Electron microscopy. Thin sections of baculovirus-infected cells embedded in Epon 812 resin were prepared as described by Addison et al. (1984) . Virus-infected cell samples for immunoelectron microscopy were embedded in Unicryl (British Bioscience International) using essentially the same method as for Lowacryl KM4 resin (Rixon et al., 1988) except that after dehydration the samples were infiltrated with 100 % Unicryl for 1 h, followed by further incubation for 1 h with fresh resin. The samples were then incubated overnight in fresh resin and the following day exposed to short-wavelength UV light for 3 days at k20 mC. The procedure for immunolocalization was essentially as described by Rixon et al. (1988) except thin sections were incubated for 2 h in diluted primary antibody instead of 45 min.
Plasmid transfections. Plasmid DNA (0n5 µg) in 25 µl 20 mM HEPES pH 7n4, 150 mM NaCl was mixed with 25 µl LipofectACE (Gibco BRL) diluted in OptiMEM (Gibco BRL). After 15 min at room temperature, 450 µl OptiMEM was added to the sample and the contents of the tube transferred on to a BHK cell monolayer (1i10& cells), previously washed twice with OptiMEM. The cells were incubated at 37 mC for 5 h, then overlaid with 450 µl Eagle's medium containing 10 % newborn calf serum and incubation continued for a further 15 h at 37 mC.
Radioactive labelling of baculovirus-infected cell polypeptides. Baculovirus-infected cells were radiolabelled with [$&S]methionine as described by Kennard et al. (1995) .
Purification of capsids containing an HSV-1 shell from baculovirus-infected cells. Capsids were isolated as described previously (Kennard et al., 1995) . Scaffold-like particles were purified using the same protocol.
Results

Expression of VZV gene 33 and 33n5 products by recombinant baculoviruses
The VZV genes 33 and 33n5 were recombined into the baculovirus expression vector AcPAK6 and recombinant baculoviruses AcVZV33 and AcVZV33n5, which express the protease and the major scaffolding protein respectively, were isolated. Baculovirus-infected cell polypeptides were labelled with [$&S]methionine and separated on an SDS-polyacrylamide gel (Fig. 1 b) . Large amounts of the VZV 33n5 product were present in AcVZV33n5-infected cells and the VZV protein was visible on a Coomassie blue-stained SDS-polyacrylamide gel of the baculovirus-infected cell extract (data not shown). By contrast, the protease was expressed poorly and only just detectable in [$&S]methionine-labelled virus-infected cell extracts ( Fig. 1 b, lane 4) . As was the case with the HSV-1 protease, the AcVZV33-infected cell polypeptide profile contained two novel bands and these are analogous to the HSV-1 protease cleavage products VP24 and VP21 (Fig. 1 b,  lanes 2 and 4) . The VZV homologue of VP21 had a similar apparent M r to the VZV 33n5 product even though its size was calculated from DNA sequence analysis to be significantly greater than the VZV major scaffolding protein (Fig. 1, lanes 3  and 4) . To confirm that viruses were expressing the VZV proteins and to compare their properties with those of HSV-1, immunoblot analysis was carried out using antibodies specific for VZV or HSV-1 scaffolding proteins. Mock-and virusinfected cell polypeptides were separated by SDS-PAGE, transferred on to nitrocellulose membranes and probed with primary antibodies. Antibody-antigen complexes were detected using Protein A conjugated to colloidal gold followed by incubation with a silver enhancing solution. When a blot of the samples was probed with VZV antibodies, which recognize sequences within the cleaved form of VZV 33n5 scaffolding protein, bands were detected in the AcVZV33n5-infected cell track which comigrated with the high M r forms present in VZV-infected CV-1 cells (Fig. 2 a, lanes 5 and 8) . The lower M r band detected in the AcVZV33n5-infected cell track is probably a breakdown product since a band of this mobility was not observed in the VZV-infected cell track. Lower M r bands which comigrated with lower M r bands present in the VZVinfected cell track, however, were present in cells coexpressing the 33n5 product and the VZV or HSV-1 protease, suggesting that both the HSV-1 and the VZV protease could cleave the VZV scaffolding protein (Fig. 2 a, lanes 6, 7 and 8 ). These lower M r forms were not detected when a blot of these samples was probed with antibody that recognized VZV carboxy-terminal sequences which were removed by the VZV 33 product, confirming that the proteases were cleaving the VZV scaffolding protein near its carboxy terminus (Fig. 2 b, lanes 6, 7 and 8). Similarly, using HSV-1-specific antibodies which recognize the cleaved form of UL26n5 and those which recognize sequences within the 25 carboxy-terminal amino acids in immunoblot analysis, the HSV-1 major scaffolding protein, the UL26n5 product, was shown to be cleaved by both the HSV-1 and VZV proteases (Fig. 2 c, d) .
Structure of the gene 33n5 product formed in baculovirus-infected cells
Cells infected with baculovirus expressing the HSV-1 UL26n5 product contain large aggregates of the protein and more rarely scaffold-like particles (Preston et al., 1994) . To VZV scaffolding protein and protease VZV scaffolding protein and protease determine whether similar structures were formed in cells infected with AcVZV33n5 or AcVZV33, thin sections of virusinfected cells were examined under the electron microscope. In AcVZV33-infected cells no distinct structures were observed, probably because the gene 33 product was present in low amounts. In AcVZV33n5-infected cells, however, large numbers of long, hollow, flexible rods, about 50 nm in diameter, were observed, mainly in the nuclei of cells. Some of these rods were arranged in parallel arrays. To confirm that the rods were formed by the 33n5 product, immunoelectron microscopy was carried out using rabbit polyclonal antibody specific for the VZV 33n5 product, tagged with goat anti-rabbit IgG coupled to colloidal gold (Fig. 3) . As a control, the immune serum against the VZV protein was replaced with preimmune rabbit serum. Clustering of gold particles over the rods was only observed in thin sections of cells that had been incubated with the immune serum, confirming that these structures were composed of the 33n5 product (compare Fig. 3 a, c) . Scaffoldlike particles were also detected in thin-section preparations of AcVZV33n5-infected cells (Fig. 3 a, b) . These particles could be cross-sections of the VZV-specific rods or spherical scaffoldlike structures. To investigate whether scaffold-like particles were present in AcVZV33n5-infected cells, an extract of these cells was analysed on a 5-40 % (w\w) sucrose gradient. The 33n5 product was present in the pellet fraction and throughout the gradient, with a greater amount of material being present near the top of the gradient, although a specific light-scattering band was not observed (data not shown). Material in pooled fractions was concentrated by high-speed centrifugation, negatively stained with sodium phosphotungstate and examined under the electron microscope. Large numbers of spherical particles were present in fractions collected near the top of the gradient (Fig. 3 e) , similar in appearance to those formed by the HSV-1 UL26n5 product extracted from capsids (Newcomb & Brown, 1991) . These particles were not uniform in size. Low numbers of scaffold-like particles and fragmented rods were observed in fractions from the middle or towards the bottom of the gradient (data not shown).
Effect of removing the 27 carboxy-terminal amino acids from the gene 33n5 product on its morphology
When the cleaved form of the HSV-1 UL26n5 product was expressed using the baculovirus system, or the full-length protein in the presence of its associated protease, large numbers of scaffold-like particles, many of which were present in regular arrays, were produced. Such structures were rarely observed when the full-length product alone was expressed (Preston et al., 1994) . To investigate whether cleavage of the VZV major scaffolding product had an effect on its morphology, cells were BGDH VZV scaffolding protein and protease VZV scaffolding protein and protease infected with AcVZV33n5a, a baculovirus expressing the cleaved form of the protein, and samples prepared for electron microscopy. Examination of thin-section preparations of virusinfected cells revealed that, in contrast to the situation with the UL26n5 product, no difference in the morphology of the 33n5 product was observed when its carboxy terminus was removed (Fig. 3 d) . Similarly, no changes in morphology of the scaffolding protein were observed in cells dually infected with AcVZV33 and AcVZV33n5 (data not shown).
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The 33n5 product interacts with HSV-1 major capsid protein VP5
The interaction of the HSV-1 UL26n5 product with VP5 is important for localization of VP5 to the nucleus and for capsid formation (Nicholson et al., 1994 ; Kennard et al., 1995 ; Matusick-Kumar et al., 1995 ; Thomsen et al., 1995) . Immunofluorescence experiments were performed to determine whether the 33n5 product could interact with HSV-1 VP5 as well as the VZV homologue. BHK cells were either singly transfected or cotransfected with plasmids carrying genes for these proteins under the control of the major IE HCMV promoter and examined at 20 h post-transfection. In cells transfected with gene 33n5 the VZV protein usually localized in discrete regions, normally but not exclusively within the nuclei, whereas in cells expressing HSV-1 VP5 or the VZV homologue alone the major capsid protein was present throughout the cell (Fig. 4 a-c) . In many of the cells containing both HSV-1 VP5 and the 33n5 protein, VP5 colocalized with the VZV protein, suggesting that these two proteins interact. Since a considerable amount of diffuse background staining was observed in both the nucleus and cytoplasm of the cells, the association of HSV-1 VP5 with the 33n5 product appeared to be weak (Fig. 4 d, e) . Similar results were obtained when the VZV major capsid protein (MCP) tagged with pp65 epitope was expressed in place of HSV-1 VP5 although the interaction of the VZV MCP with the 33n5 product appeared to be stronger than that of VP5 with the 33n5 protein, with less background nuclear and cytoplasmic fluorescence detected (Fig. 4 f, g ).
Construction of a VZV/HSV-1 chimeric scaffolding protein
In HSV-1-infected cells the major scaffolding protein and its associated protease participate in capsid shell formation. The protease, however, is not essential for the formation of capsids but is important in the release of the scaffold from the capsid Tatman et al., 1994 ; Thomsen et al., 1994 ; Gao et al., 1994) . Preliminary experiments in which the scaffold formed by the HSV-1 UL26n5 product was replaced with the VZV 33n5 product in the baculovirus HSV-1 capsid assembly system showed that the VZV protein was a poor substitute for the UL26n5 product. Electron microscopic examination of thin sections of recombinant baculovirus-infected cells containing the VZV scaffolding protein and the three essential outer shell proteins VP5, VP19C and VP23 revealed the presence of large numbers of incomplete and aberrant capsids, with few sealed capsid shells containing an internal scaffold (data not shown).
Previous work has shown that sequences at the carboxyterminal end of the full-length UL26n5 product interact with VP5 and are crucial for capsid formation (Desai & Person, 1996 ; Hong et al., 1996) . To test whether the carboxy-terminal sequences in the VZV major scaffolding protein were responsible for the inefficient assembly of HSV-1 intact capsid shells, a hybrid gene was designed in which sequences coding for the carboxy-terminal 23 amino acids of the VZV scaffolding protein were replaced with the sequences specifying the carboxy-terminal 22 amino acids from the HSV-1 UL26n5 gene (Fig. 5) . The hybrid gene was recombined into the baculovirus expression vector and the resulting recombinant virus, AcVZV33n5C, screened for the ability to make the chimeric scaffolding protein. The hybrid protein was only two amino acids shorter than its VZV counterpart and therefore was expected to migrate on an SDS-polyacrylamide gel in a similar position to the 33n5 product. Analysis of virus-infected cell polypeptides by SDS-PAGE revealed the presence in the AcVZV33n5C-infected cell polypeptide profile of large amounts of a novel protein, corresponding to the hybrid protein, which migrated significantly faster than the VZV product (Fig. 6, lanes 3 and 4) . Since amino acids flanking the maturation cleavage site between alanine and serine residues of the UL26n5 product are important for recognition and cleavage of the substrate, the chimeric protein was also examined for the ability to be processed by the HSV-1 or VZV protease (Fig. 6,  lanes 1 and 2) (DiIanni et al., 1993 b ; McCann et al., 1994) . Both proteases cleaved the chimeric protein and therefore the amino acid sequences flanking the cleavage site in the chimeric protein did not have an adverse effect on cleavage. In addition, the observation that the cleaved form of the chimeric protein comigrated with the cleaved product of the VZV scaffolding protein suggested that the carboxy-terminal sequences and not a mutation elsewhere in the protein were responsible for the aberrant mobility of the protein (Fig. 6, lanes 1, 2, 5 and 6 ). Similarly, it is possible that the discrepancy in the M r of the VZV homologue of VP21 is due to the aberrant mobility of the BGDJ V. G. Preston and others V. G. Preston and others full-length 33n5 product rather than the VZV homologue of VP21, which lacks the carboxy-terminal 27 amino acids. The sequence of the 3h end of the chimeric gene was confirmed by DNA sequence analysis of the recombinant gene inserted into the virus and the protein sequence was verified by protein blot analysis of the baculovirus-expressed protein using VZV and HSV-1 antibodies specific for the carboxy termini of the homologous proteins only (data not shown).
Comparison of HSV-1 capsid shell formation, using HSV-1, VZV and the chimeric scaffolding proteins SF cells were dually infected with AcUL18\19\38, together with a baculovirus expressing either the HSV-1, VZV or chimeric scaffolding protein. At 50 h post-infection, the cells were harvested and samples prepared for electron microscopy. Numerous capsids containing large internal scaffolds were observed in thin-section preparations of cells coinfected with AcUL26n5 and the baculovirus expressing the three essential HSV-1 capsid shell proteins (Fig. 7 a) . In cells mixedly infected with AcVZV33n5 and AcUL18\19\38, however, there were fewer scaffold-containing capsids and many of these contained small cores. Incomplete capsid shells were also observed (Fig.  7 b) as was found previously. By contrast, the population of capsids detected in cells containing the chimeric scaffolding protein, VP5, VP19C and VP23 was more uniform than those produced using the VZV scaffolding protein (Fig. 7 b, c) and similar in appearance to those formed using the UL26n5 product. To compare the efficiency of HSV-1 capsid assembly using the different scaffolding proteins, cells were multiply infected with baculoviruses AcUL18\19\38, AcUL35 and AcUL26n5 or AcVZV33n5 or AcVZV33n5C. The baculovirus AcUL35, expressing VP26, was included in the infection because higher yields of purified capsids were achieved when this capsid protein was present (F. Rixon, unpublished data) . At 72 h post-infection, cells were harvested and extracts were analysed on sucrose gradients. A strong opaque band was present in the gradient of the extract containing the chimeric scaffolding protein, in a similar position to the band of HSV-1 VP5 distribution was examined using mouse monoclonal antibody LP12 (b, d, e) and the distribution of the VZV homologue of HSV-1 VP5 using mouse monoclonal antibody 9220 (c, f, g) . The secondary antibody used in (a), (d) and ( f ) was TRITC-GAR whereas in (b), (c), (e) and (g) FITC-GAM was used. Panels (d) and (e), ( f ) and (g) represent duplicate exposures of single fields.
intermediate capsids in the gradient of the extract containing the UL26n5 protein (Fig. 7 d) . The light-scattering material higher up in the gradient was probably due to the presence of tubular structures formed by the chimeric scaffolding protein since these structures were observed in the corresponding thinsection preparations of cells. A faint band in the position of intermediate capsids was just detectable in the gradient of the sample containing the VZV 33n5 product. In addition, lightscattering material was also observed throughout the gradient and was probably a result of large numbers of incomplete and aberrant capsid structures in addition to the tubular structures. The bands were collected, diluted and the material concentrated by high-speed centrifugation. Intact capsids were detected in negatively stained preparations of the material from all the gradients (data not shown).
Predicted secondary structure of herpesvirus scaffolding proteins
The predicted secondary structure for herpesvirus scaffolding proteins was obtained using the program ProteinPredict (Rost, 1996) . Fig. 8 shows the prediction based on the alignment of seven alphaherpesvirus proteins. The amino acids conserved in the viruses used in the analysis are also indicated in Fig. 8 .
Discussion
In AcVZV33n5-infected cells, the 33n5 protein formed long, flexible hollow rods which were not observed in cells containing large amounts of the UL26n5 product. This structure was not dependent on the presence of the 27 carboxy-terminal amino acids since it was also formed by the cleaved form of the 33n5 product. The finding that the VZV protein can adopt several different structures is in keeping with the predicted secondary structure of herpesvirus scaffolding proteins. The results of this analysis suggest that the scaffolding protein is unstructured with a flexible morphology, consistent with its biological role in which it not only has to interact with the major capsid protein and assemble into a spherical structure but also has to disassemble for DNA packaging to occur. Six regions of conserved amino acids, including the protease cleavage site, were identified. Three of these regions were present in predicted helical regions of the protein, one of which contains the VP5 binding domain located near the carboxy terminus (Hong et al., 1995) . The two internal helical regions are strong candidates for sites involved in the interaction of the scaffolding protein with itself. BGEB V. G. Preston and others V. G. Preston and others Although the VZV 33n5 product has only 29 % amino acid identity with its HSV-1 counterpart, it can substitute for the HSV-1 homologue in HSV-1 capsid assembly, albeit less efficiently, using the baculovirus system. Our finding that the hybrid VZV\HSV-1 scaffolding protein was a much more effective replacement for the 26n5 product than the VZV homologue in the assembly of the HSV-1 capsid indicates that a strong interaction between VP5 and the carboxy-terminal end of the scaffolding protein is important for capsid formation and that considerable variation in the rest of the scaffolding protein is tolerated. Not only were a greater number of intact capsids produced when the chimeric protein was used instead of the VZV product as a scaffold but the population of capsids was more uniform in morphology, consisting mainly of large cored capsids. The presence of a significant number of small cored capsids in the population of intact capsids formed in the presence of the VZV 33n5 product but in the absence of the protease suggests that small cored capsids result from the loss of strong contact between the scaffold and the major capsid protein rather than a conformation change induced by cleavage near the carboxy-terminal end of the scaffolding protein. (4) is the UL26n5 product ; that in (2) is the chimeric protein and in (3) the VZV 33n5 product. (1) and (4) are the same sample.
V. G. Preston and others V. G. Preston and others Fig. 8 . Secondary structure prediction of the VZV 33n5 product using the program Predict-Protein based on the multiple alignment of the alphaherpesvirus HSV-1, HSV-2, VZV, equine herpesvirus type 1, equine herpesvirus type 4, pseudorabies virus and bovine herpesvirus type 1 proteins. The top line refers to the amino acid numberi10 − 1 , the second line is the amino acid sequence of the VZV 33n5 product, the third line is a summary of the secondary structure prediction of the protein where H l helical structure, E l extended sheet and L l loop structure, and the bottom line shows the amino acids that are conserved in the above seven alphaherpesvirus proteins using the programs Pileup and Pretty from the University of Wisconsin Genetics Computer Group (Devereux et al., 1984) , with some manual adjustments.
has 31 % amino acid identity with HSV-1 UL26n5 product, has recently been shown to act as a scaffold for HSV-1 capsid assembly using the baculovirus system (Haanes et al., 1995) and, like VZV, has 50 % amino acid identity to the UL26n5 product in the VP5 binding region near its carboxy terminus. In the study with the BHV-1 protein, however, the efficiency of capsid formation was not assessed (Haanes et al., 1995) . Although the VZV scaffolding protein can substitute for the HSV-1 homologue using the baculovirus capsid assembly system, it is not known whether the VZV 33n5 product or the chimeric protein can replace the HSV-1 UL26n5 product in an HSV-1 infection. Further experiments are underway to determine whether there are any constraints on HSV-1 viability using the VZV 33n5 or chimeric proteins together with their associated proteases.
